We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warns California Drugmaker for Testing Deficiencies, Missing Quality Unit
FDA Warns California Drugmaker for Testing Deficiencies, Missing Quality Unit
The FDA issued a warning to bB Biochem Laboratories for unsupported product expiration dates, a failure to test incoming raw materials and for having no quality unit.